News Laboratorio Farmaceutico Erfo S.p.A.

Stocks

ERFO

IT0005497885

Pharmaceuticals

Real-time Borsa Italiana Other stock markets 01:04:18 03/07/2026 pm IST			5-day change	1st Jan Change
1.160 ^EUR	-0.43%		+0.43%	-21.09%

29/06	Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares	AN
22/06	Erfo Keeps Buying Back Stock, Repurchases 28,000 Shares	AN

All News

Mentions Relevance

29/06	Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares	AN
22/06	Erfo Keeps Buying Back Stock, Repurchases 28,000 Shares	AN
15/06	Laboratorio Farmaceutico Erfo acquires 15,000 treasury shares	AN
21/05	Laboratorio Farmaceutico Erfo reports stable first-quarter revenue year-on-year	AN
21/05	Laboratorio Farmaceutico Erfo Q1 EBITDA adj. EUR 0.5 mln	RE
13/04	Laboratorio Farmaceutico Erfo S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
09/04	Laboratorio Farmaceutico Erfo S p A : Investor Presentation Erfo SpA FY2025 (ENG)	PU
30/03	Laboratorio Farmaceutico Erfo posts triple-digit profit growth in 2025	AN
19/02	Erfo Increases EBITDA in 2025; Revenues More Than Double	AN
19/02	Laboratorio Farmaceutico Erfo FY EBITDA EUR 2.0 Mln	RE
21/11	Erfo Pharmaceutical Laboratory, revenues grow by 57% in nine months	AN
21/11	Laboratorio Farmaceutico Erfo 9m Ebitda EUR 1.7 mln	RE
21/25/21	Laboratorio Farmaceutico Erfo S p A : 2025 10 20-ERFO-NextGEMS	PU
29/25/29	Erfo Pharmaceutical Laboratory improves profits in the first half	AN
29/25/29	Erfo H1 EBITDA EUR 1.2 mln	RE
27/25/27	Laboratorio Farmaceutico Erfo S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
29/25/29	Laboratorio Farmaceutico Erfo S p A : 2025 08 28 ERFO - Press release KPI 1H 2025	PU
28/25/28	Laboratorio Erfo Reports Double-Digit Growth in Revenue and EBITDA for First Half	AN
28/25/28	Laboratorio Farmaceutico Erfo H1 ebitda eur 1.2 mln	RE
14/25/14	Laboratorio Farmaceutico Erfo Purchases 13,000 Own Ordinary Shares	AN
23/25/23	Erfo Closes Warrant Exercise Period Without Conversions	AN
04/25/04	Laboratorio Farmaceutico Erfo S p A : KT Erfo 1Q25 Final	PU
23/25/23	Laboratorio Erfo, revenues and EBITDA up significantly in the quarter	AN
23/25/23	Erfo Q1 EBITDA EUR 0.5 Mln	RE
21/25/21	Erfo presents Osteo-therapy, a nutraceutical supplement	AN